As the IL12Rβ2 KD effects in AML cells are unexpected we further analysed it in KMT2A-MLLT3+ THP-1, and HL-60 AML cells that lack any KMT2A-rearrangement. The gene discussed is IL12RB2; the disease is acute myeloid leukemia.